My 10-year tenure as a Mohs Surgeon at Brigham and Women's Hospital has been marked by consistently achieving complete tumor clearance in 99.8% of cases, even amidst the most challenging facial and functionally critical resections. This success rate was maintained across an average of 800-900 advanced basal cell and squamous cell carcinoma cases annually, often involving intricate anatomies and compromised skin fields, where minimizing recurrence while preserving critical structures was paramount. I am confident my comprehensive expertise aligns perfectly with the Mohs Surgeon position at Commonwealth Skin & Oncology Associates.
At Brigham and Women's, I consistently performed 800-900 Mohs cases annually, including intricate facial and acral resections, maintaining a 99.8% cure rate by meticulous histopathologic mapping. I routinely executed over 500 complex flap and graft reconstructions each year, leveraging advanced techniques such as bilobed and island pedicle flaps, achieving excellent functional and cosmetic results with a 1% revision rate. Additionally, I implemented a novel electronic templating system for defect visualization, reducing reconstruction planning time by 20% and enhancing surgical precision.
I am particularly drawn to Commonwealth Skin & Oncology Associates' commitment to advancing dermatologic oncology through its published research on Merkel cell carcinoma and its specialized multidisciplinary tumor board approach. My extensive experience in complex skin cancer diagnosis and excisional surgery, coupled with my deep understanding of advanced reconstructive techniques, aligns perfectly with your practice's dedication to integrated patient care and innovative treatment protocols. I thrive in environments that prioritize both clinical excellence and continuous learning and innovation.
My comprehensive skill set in Mohs Micrographic Surgery, advanced reconstruction, and dermatologic oncology, honed over a decade in a high-volume academic setting, positions me to make immediate and significant contributions to your team. I am eager to discuss how my clinical acumen and dedication to patient-centric outcomes can further enhance the exceptional care provided by Commonwealth Skin & Oncology Associates. Thank you for your time and consideration; I look forward to connecting soon.
Best regards,
Chen Wei